Sinapsos Podcast | Oncology

E31   |  17 min   |   Latest   |  Publication Link

• Podcast based on: Galaal, K.; Vickery, P.J.; Marques, E.; Palmer, J.; Jones, B.; O’Shaughnessy, E.; Lopes, A.; Ewings, P.; Bekkers, R.L.M. The Trial of Intraoperative Cell Salvage Versus Transfusion in Ovarian Cancer (TIC TOC): Results of a Randomized Controlled Feasibility Study. Cancers 2026, 18, 711. https://doi.org/10.3390/cancers18040711
  Type: Article  |  Publication date: 22 February 2026
  
  
• Summary: This study looked at whether it is acceptable to use intraoperative cell salvage (ICS) during surgery for women with advanced (stage 3–4) ovarian cancer. ICS is a method that collects a patient’s own blood lost during surgery, cleans it, and gives it back to them, reducing the need for donated blood. A total of 57 women with ovarian cancer took part; the amount of blood loss during surgery was similar in both groups. In the ICS group, about two-thirds of the women who had surgery received their own salvaged blood. Women appeared comfortable with the idea of receiving their own salvaged blood. Overall, this study shows that using ICS in ovarian cancer surgery is both feasible and acceptable to patients. The findings suggest that a larger trial should now be carried out to determine whether ICS can reduce the need for donor blood and improve patient outcomes.
  
  
• Keywords: intraoperative cell salvage; blood transfusion; cytoreductive surgery; ovarian cancer; randomized feasibility trial

License and disclaimer:
Original article © 2026 by the authors. Licensed under the Creative Commons Attribution 4.0 (CC BY 4.0) license (https://creativecommons.org/licenses/by/4.0/). This episode is an AI-generated audio adaptation of the article: the script and the voices are synthetic, changes were made, and the adaptation is not endorsed by the authors, the journal, or the publisher. It may contain errors or omissions, so consult the original publication before relying on any detail. It is for educational purposes only and is not medical advice. The creators accept no liability for any use of this content.